167 related articles for article (PubMed ID: 11423224)
1. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.
O'Leary SJ; Klis SF; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2001 Apr; 154(1-2):135-45. PubMed ID: 11423224
[TBL] [Abstract][Full Text] [Related]
2. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
[TBL] [Abstract][Full Text] [Related]
3. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
[TBL] [Abstract][Full Text] [Related]
4. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs.
Konishi T; Gupta BN; Prazma J
Am J Otolaryngol; 1983; 4(1):18-26. PubMed ID: 6687035
[TBL] [Abstract][Full Text] [Related]
5. Reversible cisplatin ototoxicity in the albino guinea pig.
Klis SF; O'Leary SJ; Hamers FP; De Groot JC; Smoorenburg GF
Neuroreport; 2000 Feb; 11(3):623-6. PubMed ID: 10718325
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1997 Sep; 111(1-2):103-13. PubMed ID: 9307316
[TBL] [Abstract][Full Text] [Related]
7. Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose.
Klis SF; O'Leary SJ; Wijbenga J; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2002 Feb; 164(1-2):138-46. PubMed ID: 11950533
[TBL] [Abstract][Full Text] [Related]
8. Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.
Saito T; Manabe Y; Saito H
ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):250-5. PubMed ID: 8587776
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin.
de Groot JC; Hamers FP; Gispen WH; Smoorenburg GF
Hear Res; 1997 Apr; 106(1-2):9-19. PubMed ID: 9112103
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
11. Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig.
Sepmeijer JW; Klis SF
Hear Res; 2009 Jan; 247(1):34-9. PubMed ID: 18955125
[TBL] [Abstract][Full Text] [Related]
12. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
[TBL] [Abstract][Full Text] [Related]
13. [Effects of perilymphatic perfusion with cisplatin on the cochlear potential in guinea pigs].
Wu DZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):202-4, 254. PubMed ID: 2076322
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.
Komune S; Asakuma S; Snow JB
Otolaryngol Head Neck Surg; 1981; 89(2):275-82. PubMed ID: 6787526
[TBL] [Abstract][Full Text] [Related]
15. Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.
Hamers FP; Klis SF; Gispen WH; Smoorenburg GF
Eur Arch Otorhinolaryngol; 1994; 251(1):23-9. PubMed ID: 8179863
[TBL] [Abstract][Full Text] [Related]
16. alpha-Tocopherol protective effects on gentamicin ototoxicity: an experimental study.
Fetoni AR; Sergi B; Ferraresi A; Paludetti G; Troiani D
Int J Audiol; 2004 Mar; 43(3):166-71. PubMed ID: 15198381
[TBL] [Abstract][Full Text] [Related]
17. Quinine-induced alterations of electrically evoked otoacoustic emissions and cochlear potentials in guinea pigs.
Zheng J; Ren T; Parthasarathi A; Nuttall AL
Hear Res; 2001 Apr; 154(1-2):124-34. PubMed ID: 11423223
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside.
Kong WJ; Ren T; Nuttall AL
Hear Res; 1996 Sep; 99(1-2):22-30. PubMed ID: 8970810
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of adenosine receptors in the cochlea by cisplatin.
Ford MS; Nie Z; Whitworth C; Rybak LP; Ramkumar V
Hear Res; 1997 Sep; 111(1-2):143-52. PubMed ID: 9307320
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1998 Oct; 124(1-2):108-17. PubMed ID: 9822908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
